Startseite>>Lipids>> Sphingolipids>>UGT8 Inhibitor 19

UGT8 Inhibitor 19 (Synonyms: Ceramide Galactosyltransferase Inhibitor 19, CGT Inhibitor 19, UDP-galactose Ceramide Galactosyltransferase Inhibitor 19)

Katalog-Nr.GC49035

An inhibitor of UGT8

Products are for research use only. Not for human use. We do not sell to patients.

UGT8 Inhibitor 19 Chemische Struktur

Cas No.: 2414349-93-0

Größe Preis Lagerbestand Menge
1 mg
67,00 $
Auf Lager
5 mg
317,00 $
Auf Lager
10 mg
602,00 $
Auf Lager
25 mg
1.252,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

UGT8 inhibitor 19 is an inhibitor of UDP-galactose ceramide galactosyltransferase (UGT8), also known as ceramide galactosyltranferase (CGT; IC50 = 0.2 nM).1 It is selective for UGT8 over UGT1A1, -1A6, -2B7, -2B15, and -2B17 (IC50s = >10 µM for all). In vivo, UGT8 inhibitor 19 inhibits the synthesis of galactosylceramide (GalCer) and sulfatide (SFT) in juvenile mouse brain (ED50s = <3 mg/kg for both) and adult mouse kidney when administered at doses of 3, 10, and 30 mg/kg.

1.Burton, M.A., Antoun, E., Penailillo, R.S., et al.Folic acid induces intake-related changes in the mammary tissue transcriptome of C57BL/6 miceNutrients12(9)2821(2020)

Bewertungen

Review for UGT8 Inhibitor 19

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for UGT8 Inhibitor 19

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.